Table 1.
Demographics and clinicopathologic characteristics of patients
| NACT group | nNACT group | |
|---|---|---|
| No. of patients | 56 | 46 |
| Gender, n (%) | ||
| Male | 44 (78.6) | 34 (73.9) |
| Female | 12 (21.4) | 12 (26.1) |
| Age, n (%) | ||
| <55 | 26 (46.4) | 22 (47.8) |
| ≥55 | 30 (53.6) | 24 (52.2) |
| Differentiation, n (%) | ||
| Well/moderately differentiated | 20 (35.7) | 10 (21.7) |
| Poorly differentiated | 36 (64.3) | 36 (78.3) |
| Invasion depth, n (%) | ||
| T2 | 9 (16.1) | 6 (13.0) |
| T3/T4 | 47 (83.9) | 40 (87.0) |
| TNM Stage, n (%) | ||
| I+II | 22 (39.3) | 10 (21.7) |
| III+IV | 34 (60.7) | 36 (78.3) |
| Lymph node metastasis, n (%) | ||
| No (N0) | 21 (37.5) | 16 (34.8) |
| Yes (N1, N2, N3) | 35 (62.5) | 30 (65.2) |
| Clinical Status at follow-up, n (%) | ||
| Dead or died with recurrence | 33 (58.9) | 26 (56.5) |
| Live and without recurrence | 23 (41.1) | 20 (43.5) |
| 15-PGDH expression | ||
| Low, n (%) | 8 (14.3) | 30 (65.2) |
| High, n (%) | 48 (85.7) | 16 (34.8) |
T2, tumour invasion of the muscularis propria or subserosa; T3, tumour invasion extends to or beyond the serosa; T4, tumour invasion of adjacent structures; well-moderately: well-moderately differentiated carcinoma; Poorly: poorly differentiated carcinoma.